查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1663500

芹菜素市场，按来源、形式、应用、国家和地区划分 - 2025 年至 2032 年全球产业分析、市场规模、市场份额和预测

Apigenin Market, By Source, By Form, By Application, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 269 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年芹菜素市场规模价值为 37.2032 亿美元，2025 年至 2032 年期间复合年增长率为 4.50%。

芹菜素市场-市场动态

製药和营养品产业对天然抗氧化剂和抗癌化合物的需求不断增加

随着消费者健康意识的不断增强，他们越来越倾向于选择植物性和天然化合物，而非合成化合物，因为它们的副作用较小，而且对健康有益。芹菜素以其强大的抗氧化特性而闻名，有助于对抗氧化压力，这是心血管疾病、神经退化性疾病和衰老相关问题等慢性病的关键因素。此外，其诱导细胞凋亡和抑制肿瘤细胞增殖等抗癌作用使其在癌症预防和治疗研究中备受追捧。在营养保健食品中，芹菜素越来越多地用于针对免疫支持、抗发炎作用和整体健康的膳食补充剂中，反映了对预防性医疗保健解决方案日益增长的需求。根据印度传统医学部的报告，由于政府支持的推广传统医药和草药的倡议，包括天然抗氧化剂在内的全球植物性健康产品市场正在大幅成长。这种转变符合更广泛的健康趋势，即青睐天然化合物而非合成成分，凸显了芹菜素在塑造药品和营养保健品未来方面的关键作用。永续采购和技术进步将进一步增强其市场潜力。

芹菜素市场 - 关键见解

  • 根据我们的研究分析师的分析，预测期内（2025-2032 年），全球市场预计年复合成长率约为 4.50%
  • 根据来源细分，预计天然将在 2024 年占据最大市场份额
  • 根据应用细分，食品和饮料是 2024 年的领先细分市场
  • 从地区来看，北美是 2024 年最大的收入来源

芹菜素市场-細項分析：

全球芹菜素市场根据来源、形式、应用和地区进行细分。

根据来源，市场分为两类：天然和合成。由于消费者越来越青睐植物性、环保、副作用小、健康益处明显的产品，天然产品在市场上占据了主导地位。此外，对有机成分的监管支持进一步推动了对芹菜素等天然化合物的需求。

根据应用，市场分为四类：药品、食品和饮料、化妆品和个人护理以及膳食补充剂。食品和饮料因其广泛用作天然抗氧化剂和防腐剂、延长产品保质期和营养价值而占据市场主导地位。消费者对富含有益健康的生物活性化合物的功能性食品和饮料的需求不断增长，进一步推动了其主导地位。

芹菜素市场-地理洞察

在北美，特别是美国，消费者对药品、营养品和功能性食品中的天然和植物成分的偏好日益增长，使其成为芹菜素的主要市场之一。人们对抗氧化剂和抗癌化合物的健康益处的认识不断提高，这支持了这一需求。此外，强而有力的监管框架和研究的进步也促进了该地区市场的成长。在欧洲，由于食品、饮料和个人护理领域中有机和天然产品的流行趋势日益增长，市场正在不断扩大。欧盟对食品和化妆品中合成化学物质的严格规定增加了芹菜素等植物成分的采用，进一步推动了市场成长。亚太地区，尤其是印度和中国等国家，芹菜素市场正在快速成长，这得益于人们日益转向传统草药和保健品和食品中的天然产品。政府倡导在医疗保健中使用草药和天然成分的措施也促进了该地区市场的扩张。

芹菜素市场－竞争格局：

芹菜素市场竞争激烈，许多参与者致力于满足市场对天然抗氧化剂和健康促进化合物日益增长的需求。主要市场参与者采用产品创新、合作伙伴关係和协作等各种策略来巩固其市场地位。各公司正在投资研发，以提高芹菜素的生物利用度和有效性，推动其在药品、营养品和化妆品中的应用。此外，向植物和有机成分的转变导致供应商之间的竞争加剧，以从天然和永续来源获取高品质的芹菜素。就市场占有率而言，製药和营养保健品产业竞争激烈，各企业争相获得监管部门批准，并开发出吸引註重健康的消费者的配方。食品和饮料行业也面临竞争，製造商在功能性食品和饮料中加入芹菜素，以满足对富含抗氧化剂的产品日益增长的需求。此外，化妆品行业越来越多地利用芹菜素的抗衰老和舒缓皮肤的特性，加剧了美容和个人护理市场的竞争。市场的全球化性质鼓励参与者扩大国际影响力，探索亚太地区和拉丁美洲等新的区域市场，这些地区的消费者对自然健康解决方案的需求正在迅速增长。

最新动态：

  • 2024 年 5 月，Tally Health 推出了恢復睡眠和长寿配方，这是针对改善睡眠和整体延长寿命的成分混合物。配方结合了多种植物药和营养保健品，旨在促进放鬆并减少与年龄相关的健康问题。
  • 2024 年 4 月，4Life 推出了 Transfer Factor AgePro，这是一款将芹菜素与其他强效化合物结合的新产品，旨在增强免疫支持并促进长寿。该产品秉承 4Life 对科学支援的配方和专有成分（包括独家植物萃取物）的承诺，旨在促进健康和保健。

目录

第 1 章：芹菜素市场概述

  • 研究范围
  • 市场估计年限

第 2 章：执行摘要

  • 市场片段
    • 芹菜素市场片段（依来源）
    • 芹菜素市场片段（依形式）
    • 芹菜素市场片段（依应用）
    • 芹菜素市场（按国家）摘要
    • 芹菜素市场片段（按地区）
  • 竞争洞察

第 3 章：芹菜素主要市场趋势

  • 芹菜素市场驱动因素
    • 市场驱动因素的影响分析
  • 芹菜素市场限制
    • 市场限制的影响分析
  • 芹菜素的市场机会
  • 芹菜素市场未来趋势

第 4 章：芹菜素产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景规划
  • 规范架构分析

第 5 章：芹菜素市场：地缘政治紧张局势升级的影响

  • 新冠肺炎疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第 6 章：芹菜素市场格局

  • 芹菜素市占率分析，2024 年
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第 7 章：芹菜素市场 - 按来源

  • 概述
    • 按来源分類的细分市场占有率分析
    • 自然的
    • 合成的

第 8 章：芹菜素市场 - 按形式

  • 概述
    • 按形式细分的份额分析
    • 粉末
    • 液体

第 9 章：芹菜素市场 - 依应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 药品
    • 食品和饮料
    • 化妆品和个人护理
    • 膳食补充剂
    • 其他的

第 10 章：芹菜素市场 - 按地区划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美芹菜素主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模与预测，依来源划分
    • 北美市场规模及预测（按形式）
    • 北美市场规模与预测，按应用划分
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲芹菜素主要製造商
    • 欧洲市场规模及预测（按国家）
    • 欧洲市场规模与预测，按来源
    • 欧洲市场规模及预测（按形式）
    • 欧洲市场规模和预测，按应用
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区芹菜素主要製造商
    • 亚太地区市场规模及预测（依国家/地区划分）
    • 亚太地区市场规模及预测（依来源划分）
    • 亚太地区市场规模及预测（依形式）
    • 亚太地区市场规模及预测（按应用划分）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲 (LATAM)
    • 概述
    • 拉丁美洲芹菜素主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（按来源划分）
    • 拉丁美洲市场规模及预测（按形式）
    • 拉丁美洲市场规模及预测（按应用划分）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲 (MEA)
    • 概述
    • 中东和非洲的芹菜素主要製造商
    • MEA 市场规模及预测（依国家/地区划分）
    • MEA 市场规模和预测，按来源
    • MEA 市场规模和预测（按形式）
    • MEA 市场规模及预测（按应用）
    • 沙乌地阿拉伯
    • 阿联酋
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其他地区

第 11 章：主要供应商分析-芹菜素产业

  • 竞争仪錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Monteloeder SL
    • Sigma-Aldrich Corporation
    • Aksuvital GIda Sanayi ve Ticaret AS
    • Bo International Pvt. Ltd.
    • Indo Phytochem Pharmaceuticals Pvt. Ltd.
    • Shaanxi QingLan Bio-Technology Co., Ltd.
    • Xi'an Incedit Bio-Tech Co., Ltd.
    • Xi'an Sost Biotech Co., Ltd.
    • Shaanxi Pioneer Biotech Co., Ltd.
    • Xi'an Lyphar Biotech Co., Ltd.
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4688

REPORT HIGHLIGHT

Apigenin Market size was valued at US$ 3,720.32 Million in 2024, expanding at a CAGR of 4.50% from 2025 to 2032.

Apigenin is a bioactive flavonoid widely found in fruits, vegetables, and herbs, particularly in parsley, celery, and chamomile. It is renowned for its antioxidant, anti-inflammatory, and anti-cancer properties. Structurally belonging to the flavone class, apigenin plays a crucial role in health and wellness industries due to its diverse therapeutic benefits and minimal side effects compared to synthetic drugs. The growing need for apigenin is driven by its significant health benefits. As a potent antioxidant, it neutralizes free radicals, reducing oxidative stress, a key factor in aging and chronic diseases. Its anti-inflammatory effects make it valuable for managing arthritis and cardiovascular disorders. Apigenin is also gaining attention in oncology, where it has demonstrated the ability to induce apoptosis and inhibit tumor growth in cancers such as breast, prostate, and colon. Furthermore, its neuroprotective properties support brain health by promoting neuron formation and reducing the risk of neurodegenerative diseases like Alzheimer's. In the cosmetics industry, apigenin is used for its skin-soothing and anti-aging properties, enhancing product formulations aimed at skin rejuvenation. Additionally, its incorporation into dietary supplements addresses consumer demand for natural health-enhancing ingredients, making it a critical compound in various sectors, from pharmaceuticals to nutraceuticals.

Apigenin Market- Market Dynamics

Increasing demand for natural antioxidants and anti-cancer compounds across pharmaceuticals and nutraceutical industries

Increasing health awareness among consumers has led to a rising preference for plant-based and naturally derived compounds over synthetic alternatives, given their reduced side effects and holistic health benefits. Apigenin, known for its potent antioxidant properties, helps combat oxidative stress, a key factor in chronic conditions such as cardiovascular disease, neurodegenerative disorders, and aging-related issues. Furthermore, its anti-cancer effects-such as inducing apoptosis and inhibiting tumor cell proliferation-make it highly sought after in cancer prevention and treatment research. In nutraceuticals, apigenin is increasingly used in dietary supplements targeting immune support, anti-inflammatory effects, and general wellness, reflecting the growing demand for preventive healthcare solutions. According to a report from the Indian Ministry of AYUSH, the global market for plant-based health products, including natural antioxidants, is experiencing substantial growth due to government-backed initiatives promoting traditional and herbal medicines. This shift aligns with broader health trends favoring natural compounds over synthetic ingredients, highlighting the critical role of apigenin in shaping the future of pharmaceuticals and nutraceuticals. Sustainable sourcing and technological advancements will further enhance its market potential.

Apigenin Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.50% over the forecast period (2025-2032)
  • Based on Source segmentation, Natural was predicted to show maximum market share in the year 2024
  • Based on Application segmentation, Food & Beverages was the leading segment in 2024
  • On the basis of region, North America was the leading revenue generator in 2024

Apigenin Market- Segmentation Analysis:

The Global Apigenin Market is segmented on the basis of Source, Form, Application, and Region.

The market is divided into two categories based on Source: Natural and Synthetic. Natural dominates the market due to increasing consumer preference for plant-based, eco-friendly products with minimal side effects and proven health benefits. Additionally, regulatory support for organic ingredients further drives demand for naturally sourced compounds like apigenin.

The market is divided into four categories based on Application: Pharmaceuticals, Food & Beverages, Cosmetics & Personal Care, and Dietary Supplements. Food & Beverages dominates the market due to its widespread use as a natural antioxidant and preservative, enhancing product shelf life and nutritional value. Growing consumer demand for functional foods and beverages enriched with health-promoting bioactive compounds further drives its dominance.

Apigenin Market- Geographical Insights

In North America, particularly the United States, there is a growing consumer preference for natural and plant-based ingredients in pharmaceuticals, nutraceuticals, and functional foods, making it one of the leading markets for apigenin. This demand is supported by increasing awareness of the health benefits of antioxidants and anti-cancer compounds. Additionally, the robust regulatory framework and advancements in research contribute to the market's growth in this region. In Europe, the market is expanding due to the rising trend of organic and natural products in food, beverages, and personal care. The European Union's stringent regulations on synthetic chemicals in food and cosmetics have increased the adoption of plant-derived ingredients like apigenin, further fueling market growth. The Asia-Pacific region, especially countries like India and China, is witnessing rapid growth in the apigenin market, driven by a growing shift toward traditional herbal remedies and natural products in health supplements and food. Government initiatives promoting the use of herbal and natural ingredients in healthcare also contribute to the market's expansion in this region.

Apigenin Market- Competitive Landscape:

The Apigenin market is characterized by a competitive landscape with numerous players focused on capitalizing on the increasing demand for natural antioxidants and health-promoting compounds. Key market players adopt various strategies such as product innovation, partnerships, and collaborations to strengthen their market position. Companies are investing in research and development to enhance the bioavailability and effectiveness of apigenin, driving its application across pharmaceuticals, nutraceuticals, and cosmetics. Additionally, the shift towards plant-based and organic ingredients has led to heightened competition among suppliers to source high-quality apigenin from natural and sustainable sources. In terms of market share, the pharmaceutical and nutraceutical sectors are highly competitive, with businesses vying to secure regulatory approvals and develop formulations that appeal to health-conscious consumers. The food and beverages sector also sees competition, with manufacturers incorporating apigenin in functional foods and beverages to cater to the rising demand for antioxidant-rich products. Moreover, the cosmetics industry is increasingly leveraging apigenin for its anti-aging and skin-soothing properties, intensifying competition in the beauty and personal care market. The global nature of the market encourages players to expand their footprint internationally, exploring new regional markets such as Asia-Pacific and Latin America, where consumer demand for natural health solutions is rapidly growing.

Recent Developments:

  • In May 2024, Tally Health launched its Restore Sleep and Longevity Formula, a blend of ingredients targeting improved sleep and overall longevity. The formula combines several botanicals and nutraceuticals aimed at promoting relaxation and reducing age-related health issues.
  • In April 2024, 4Life launched Transfer Factor AgePro, a new product combining apigenin with other powerful compounds aimed at enhancing immune support and promoting longevity. This product builds on 4Life's commitment to scientifically backed formulations and proprietary ingredients, including exclusive plant extracts, designed to boost health and wellness.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL APIGENIN MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Monteloeder S.L.
  • Sigma-Aldrich Corporation
  • Aksuvital GIda Sanayi ve Ticaret A.S.
  • Bo International Pvt. Ltd.
  • Indo Phytochem Pharmaceuticals Pvt. Ltd.
  • Shaanxi QingLan Bio-Technology Co., Ltd.
  • Xi'an Incedit Bio-Tech Co., Ltd.
  • Xi'an Sost Biotech Co., Ltd.
  • Shaanxi Pioneer Biotech Co., Ltd.
  • Xi'an Lyphar Biotech Co., Ltd.
  • Others

GLOBAL APIGENIN MARKET, BY SOURCE- MARKET ANALYSIS, 2019 - 2032

  • Natural
  • Synthetic

GLOBAL APIGENIN MARKET, BY FORM - MARKET ANALYSIS, 2019 - 2032

  • Powder
  • Liquid

GLOBAL APIGENIN MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceuticals
  • Food & Beverages
  • Cosmetics & Personal Care
  • Dietary Supplements
  • Others

GLOBAL APIGENIN MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Apigenin Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Apigenin Market Snippet by Source
    • 2.1.2. Apigenin Market Snippet by Form
    • 2.1.3. Apigenin Market Snippet by Application
    • 2.1.4. Apigenin Market Snippet by Country
    • 2.1.5. Apigenin Market Snippet by Region
  • 2.2. Competitive Insights

3. Apigenin Key Market Trends

  • 3.1. Apigenin Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Apigenin Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Apigenin Market Opportunities
  • 3.4. Apigenin Market Future Trends

4. Apigenin Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Apigenin Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Apigenin Market Landscape

  • 6.1. Apigenin Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Apigenin Market - By Source

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Source, 2024 & 2032 (%)
    • 7.1.2. Natural
    • 7.1.3. Synthetic

8. Apigenin Market - By Form

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Form, 2024 & 2032 (%)
    • 8.1.2. Powder
    • 8.1.3. Liquid

9. Apigenin Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Pharmaceuticals
    • 9.1.3. Food & Beverages
    • 9.1.4. Cosmetics & Personal Care
    • 9.1.5. Dietary Supplements
    • 9.1.6. Others

10. Apigenin Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Apigenin Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Apigenin Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Apigenin Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Apigenin Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Apigenin Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Apigenin Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Monteloeder S.L.
    • 11.2.2. Sigma-Aldrich Corporation
    • 11.2.3. Aksuvital GIda Sanayi ve Ticaret A.S.
    • 11.2.4. Bo International Pvt. Ltd.
    • 11.2.5. Indo Phytochem Pharmaceuticals Pvt. Ltd.
    • 11.2.6. Shaanxi QingLan Bio-Technology Co., Ltd.
    • 11.2.7. Xi'an Incedit Bio-Tech Co., Ltd.
    • 11.2.8. Xi'an Sost Biotech Co., Ltd.
    • 11.2.9. Shaanxi Pioneer Biotech Co., Ltd.
    • 11.2.10. Xi'an Lyphar Biotech Co., Ltd.
    • 11.2.11. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us